Beam Therapeutics' growing pipeline could reward patient investors.

Treatment-resistant depression drug Xanamem has produced statistically significant antidepressant effects in a peer-reviewed ...

Discover how Indian universities and startups are driving a shift toward deep tech innovation. Learn about the challenges of ...

After Eli Lilly dived into the psychedelics space with a $2.8 billion upfront acquisition of AtaiBeckley last week, industry experts told Fierce that the deal would give the space added momentum. The ...